Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

NCT01214889 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Poliomyelitis
Haemophilus Influenzae Type B

Interventions

BIOLOGICAL: PENTAXIM™: DTacP IPV//PRP~T combined vaccine
BIOLOGICAL: TETRAXIM™: DTacP IPV combined vaccine and ActHIB™: PRP tetanus conjugate vaccine

Sponsor

Sanofi